Multiple Sclerosis Trial, Recruiting (NCT05388331)

Multiple Sclerosis Trial, Recruiting NCT05388331 Sponsor: Centre Hospitalier Universitaire de Nice Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT05388331 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have certain bright spots on a specific type of brain scan (MRI) that suggest damage to the protective coating around nerve fibres
You have no symptoms related to these brain scan findings
Your neurological examination (tests of your nervous system, such as reflexes, coordination, and movement) came back normal

Who may not be able to join:

Your neurological examination showed abnormal results
Your doctor suspects that a different condition (other than demyelination) could be causing the spots seen on your brain scan

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 33 4 92 03 41 26

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05388331

Sponsor: Centre Hospitalier Universitaire de Nice

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

Trial contact: 33 4 92 03 41 26

More information: https://clinicaltrials.gov/study/NCT05388331

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have certain bright spots on a specific type of brain scan (MRI) that suggest damage to the protective coating around nerve fibres
You have no symptoms related to these brain scan findings
Your neurological examination (tests of your nervous system, such as reflexes, coordination, and movement) came back normal

Who may not be able to join:

Your neurological examination showed abnormal results
Your doctor suspects that a different condition (other than demyelination) could be causing the spots seen on your brain scan

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Centre Hospitalier Universitaire de Nice

Registry

ClinicalTrials.gov

Start date

15 April 2022

Est. completion

15 April 2023

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Identification of lesions T2-weighted sequence at the index scan; Identification of lesions T2-weighted sequence at the index scan; Identification of lesions T1 sequence with and without Gd at the index scan.; Identification of lesions T1 sequence with and without Gd at the index scan.; Radiological progression : new T2 lesions; Radiological progression : new contrast enhancing lesions; Radiological progression : new contrast enhancing lesions; Brain atrophy; Brain atrophy; Brain atrophy; Brain atrophy; Brain atrophy; Brain atrophy; Radiological progression : new T2 lesions; Radiological progr...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov